<code id='170F551829'></code><style id='170F551829'></style>
    • <acronym id='170F551829'></acronym>
      <center id='170F551829'><center id='170F551829'><tfoot id='170F551829'></tfoot></center><abbr id='170F551829'><dir id='170F551829'><tfoot id='170F551829'></tfoot><noframes id='170F551829'>

    • <optgroup id='170F551829'><strike id='170F551829'><sup id='170F551829'></sup></strike><code id='170F551829'></code></optgroup>
        1. <b id='170F551829'><label id='170F551829'><select id='170F551829'><dt id='170F551829'><span id='170F551829'></span></dt></select></label></b><u id='170F551829'></u>
          <i id='170F551829'><strike id='170F551829'><tt id='170F551829'><pre id='170F551829'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:771
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Dramatically reducing cancer deaths requires the PASTEUR Act
          Dramatically reducing cancer deaths requires the PASTEUR Act

          ThesuperbugStaphylcocusepidermidisisshownonanagarplate.Morethan3millionAmericansdevelopadrug-resista

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Children’s Hospital revives plan for pedestrian bridge

          ArenderingoftheLongwoodAvenuefootbridgeBostonChildren’sHospitalplanstobuild.Elkus/ManfrediArchitects